Publications by authors named "J Godoi"

Background:  Spinal muscular atrophy linked to chromosome 5q (SMA-5q) is a neurodegenerative disorder caused by mutations in the gene.

Objective:  To describe the key demographic, clinical and genetic characteristics, as well as natural history data of patients with SMA-5q.

Methods:  Up to January 2022, 706 patients with confirmed genetic diagnosis of SMA-5q, or their parents, completed a self-reported questionnaire on natural history, genetic characteristics, drug treatments, and multidisciplinary care.

View Article and Find Full Text PDF

Although very few controlled studies are available, in utero Zika virus (ZIKV)-exposed children are considered at risk for neurodevelopmental abnormalities. We aimed to identify whether there is an excess risk of abnormalities in non-microcephalic children born to mothers with confirmed ZIKV infection compared with ZIKV-unexposed children from the same population. In a cross-sectional study nested in two larger cohorts, we compared 324 ZIKV-exposed children with 984 unexposed controls.

View Article and Find Full Text PDF

Atmospheric Particulate Matter (PM) is a pollutant with diverse origins, exhibiting varying chemical compositions, and undergoes several molecular transformations in the atmosphere. In this study, PM samples (PM, PM and TSP) were collected in five Brazilian cities (Camboriú-SC; Catalão-GO; Florianópolis-SC; Limeira-SP and Novo Hamburgo-RS) during the four seasons of the year. Analysis of Variance (ANOVA) was used to evaluate the differences between each city and season in PM concentration.

View Article and Find Full Text PDF

Background: The prevalence of atherosclerosis is higher in HIV-positive people, who also experience it earlier than the general population.

Objectives: To assess and compare the prevalence of atherosclerosis evaluated by the intima-media thickness of carotid and femoral arteries, and by the ankle-brachial pressure index (ABPI) in HIV patients treated or not treated with protease inhibitors (PIs) and controls.

Methods: Eighty HIV+ subjects (40 using PIs and 40 not using PIs) and 65 controls were included in the study.

View Article and Find Full Text PDF